The Journal of Thoracic and Cardiovascular Surgery
Volume 135, Issue 5 , Pages 1022-1028 , May 2008

Extension of survival by resection of asynchronous renal cell carcinoma metastases to mediastinal lymph nodes

  • Bryan A. Whitson, MD

      Affiliations

    • Department of Surgery, University of Minnesota, Minneapolis, Minn
    • ,
  • Shawn S. Groth, MD

      Affiliations

    • Department of Surgery, University of Minnesota, Minneapolis, Minn
    • ,
  • Rafael S. Andrade, MD

      Affiliations

    • Department of Surgery, University of Minnesota, Minneapolis, Minn
    • ,
  • Laurel Garrett, BS

      Affiliations

    • Department of Surgery, University of Minnesota, Minneapolis, Minn
    • ,
  • Arkadiusz Z. Dudek, MD, PhD

      Affiliations

    • Department of Medicine, University of Minnesota, Minneapolis, Minn
    • ,
  • Jose Jessurun, MD

      Affiliations

    • Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, Minn
    • ,
  • Michael A. Maddaus, MD

      Affiliations

    • Department of Surgery, University of Minnesota, Minneapolis, Minn
    • Corresponding Author InformationAddress for reprints: Michael A. Maddaus, MD, Professor and Program Director, University of Minnesota Department of Surgery, MMC 207, 420 Delaware St SE, Minneapolis, MN 55455.

Received 2 July 2007 ,Revised 27 November 2007 ,Accepted 18 December 2007.

References 

  1. Guinan P, Sobin LH, Algaba F, Badellino F, Kameyama S, MacLennan G, et al. TNM staging of renal cell carcinoma: Workgroup No. 3. Union International Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC). Cancer. 1997;80:992–993
  2. Eggener SE, Yossepowitch O, Pettus JA, Snyder ME, Motzer RJ, Russo P. Renal cell carcinoma recurrence after nephrectomy for localized disease: predicting survival from time of recurrence. J Clin Oncol. 2006;24:3101–3106
  3. Motzer RJ, Bacik J, Schwartz LH, Reuter V, Russo P, Marion S, et al. Prognostic factors for survival in previously treated patients with metastatic renal cell carcinoma. J Clin Oncol. 2004;22:454–463
  4. Hofmann HS, Neef H, Krohe K, Andreev P, Silber RE. Prognostic factors and survival after pulmonary resection of metastatic renal cell carcinoma. Eur Urol. 2005;48:77–81discussion 81-2
  5. Vogl UM, Zehetgruber H, Dominkus M, Hejna M, Zielinski CC, Haitel A, et al. Prognostic factors in metastatic renal cell carcinoma: metastasectomy as independent prognostic variable. Br J Cancer. 2006;95:691–698
  6. Murthy SC, Kim K, Rice TW, Rajeswaran J, Bukowski R, DeCamp MM, et al. Can we predict long-term survival after pulmonary metastasectomy for renal cell carcinoma?. Ann Thorac Surg. 2005;79:996–1003
  7. Pfannschmidt J, Hoffmann H, Muley T, Krysa S, Trainer C, Dienemann H. Prognostic factors for survival after pulmonary resection of metastatic renal cell carcinoma. Ann Thorac Surg. 2002;74:1653–1657
  8. Fuhrman SA, Lasky LC, Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol. 1982;6:655–663
  9. Mai KT, Landry DC, Robertson SJ, Commons AS, Burns BF, Thijssen A, et al. A comparative study of metastatic renal cell carcinoma with correlation to subtype and primary tumor. Pathol Res Pract. 2001;197:671–675
  10. Ficarra V, Righetti R, Martignoni G, D'Amico A, Pilloni S, Rubilotta E, et al. Prognostic value of renal cell carcinoma nuclear grading: multivariate analysis of 333 cases. Urol Int. 2001;67:130–134
  11. Ficarra V, Righetti R, Pilloni S, D'Amico A, Maffei N, Novella G, et al. Prognostic factors in patients with renal cell carcinoma: retrospective analysis of 675 cases. Eur Urol. 2002;41:190–198
  12. Green LK, Ayala AG, Ro JY, Swanson DA, Grignon DJ, Giacco GG, et al. Role of nuclear grading in stage I renal cell carcinoma. Urology. 1989;34:310–315
  13. Bruno JJ, Snyder ME, Motzer RJ, Russo P. Renal cell carcinoma local recurrences: impact of surgical treatment and concomitant metastasis on survival. BJU Int. 2006;97:933–938
  14. Lee SE, Kwak C, Byun SS, Gill MC, Chang IH, Kim YJ, et al. Metastatectomy prior to immunochemotherapy for metastatic renal cell carcinoma. Urol Int. 2006;76:256–263
  15. Gogus C, Baltaci S, Beduk Y, Sahinli S, Kupeli S, Gogus O. Isolated local recurrence of renal cell carcinoma after radical nephrectomy: experience with 10 cases. Urology. 2003;61:926–929
  16. Pfannschmidt J, Klode J, Muley T, Dienemann H, Hoffmann H. Nodal involvement at the time of pulmonary metastasectomy: experiences in 245 patients. Ann Thorac Surg. 2006;81:448–454
  17. Poncelet AJ, Lurquin A, Weynand B, Humblet Y, Noirhomme P. Prognostic factors for long-term survival in patients with thoracic metastatic disease: a 10-year experience. Eur J Cardiothorac Surg. 2007;31:173–180
  18. Takanami I, Naruke M, Kodaira S. Long-term survival after resection of a mediastinal metastasis from a renal cell carcinoma. J Thorac Cardiovasc Surg. 1998;115:1218–1219
  19. Motzer RJ, Bander NH, Nanus DM. Renal-cell carcinoma. N Engl J Med. 1996;335:865–875
  20. Rosenberg SA, Lotze MT, Muul LM, Chang AE, Avis FP, Leitman S, et al. A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone. N Engl J Med. 1987;316:889–897
  21. Lee DS, White DE, Hurst R, Rosenberg SA, Yang JC. Patterns of relapse and response to retreatment in patients with metastatic melanoma or renal cell carcinoma who responded to interleukin-2–based immunotherapy. Cancer J Sci Am. 1998;4:86–93

PII: S0022-5223(08)00037-8

doi: 10.1016/j.jtcvs.2007.12.016

The Journal of Thoracic and Cardiovascular Surgery
Volume 135, Issue 5 , Pages 1022-1028 , May 2008

Article Tools

* Image Usage & Resolution